220 related articles for article (PubMed ID: 29486766)
21. Amplification of GTP-cyclohydrolase 1 gene in Plasmodium falciparum isolates with the quadruple mutant of dihydrofolate reductase and dihydropteroate synthase genes in Ghana.
Osei M; Ansah F; Matrevi SA; Asante KP; Awandare GA; Quashie NB; Duah NO
PLoS One; 2018; 13(9):e0204871. PubMed ID: 30265714
[TBL] [Abstract][Full Text] [Related]
22. Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017.
Hussien M; Abdel Hamid MM; Elamin EA; Hassan AO; Elaagip AH; Salama AHA; Abdelraheem MH; Mohamed AO
PLoS One; 2020; 15(8):e0235401. PubMed ID: 32817665
[TBL] [Abstract][Full Text] [Related]
23. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H.
Pacheco MA; Schneider KA; Cheng Q; Munde EO; Ndege C; Onyango C; Raballah E; Anyona SB; Ouma C; Perkins DJ; Escalante AA
Malar J; 2020 Oct; 19(1):378. PubMed ID: 33092587
[TBL] [Abstract][Full Text] [Related]
24. Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine-pyrimethamine in central Africa: a cross-sectional study.
Guémas E; Coppée R; Ménard S; du Manoir M; Nsango S; Makaba Mvumbi D; Nakoune E; Eboumbou Moukoko CE; Bouyou Akotet MK; Mirabeau TY; Manguin S; Malekita Yobi D; Akiana J; Kouna LC; Mawili Mboumba DP; Voumbo-Matoumona DF; Otam AL; Rubbo PA; Lombart JP; Kwanai E; Cohen O; Iriart X; Ayong L; Lekana-Douki JB; Ariey F; Berry A
Lancet Microbe; 2023 Dec; 4(12):e983-e993. PubMed ID: 37865113
[TBL] [Abstract][Full Text] [Related]
25. Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana.
Duah NO; Quashie NB; Abuaku BK; Sebeny PJ; Kronmann KC; Koram KA
Am J Trop Med Hyg; 2012 Dec; 87(6):996-1003. PubMed ID: 23045251
[TBL] [Abstract][Full Text] [Related]
26.
Somé AF; Conrad MD; Kabré Z; Fofana A; Yerbanga RS; Bazié T; Neya C; Somé M; Kagambega TJ; Legac J; Garg S; Bailey JA; Ouédraogo J-B; Rosenthal PJ; Cooper RA
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0153423. PubMed ID: 38411062
[TBL] [Abstract][Full Text] [Related]
27. Systematic Review and Geospatial Modeling of Molecular Markers of Resistance to Artemisinins and Sulfadoxine-Pyrimethamine in Plasmodium falciparum in India.
Nain M; Dhorda M; Flegg JA; Gupta A; Harrison LE; Singh-Phulgenda S; Otienoburu SD; Harriss E; Bharti PK; Behera B; Rahi M; Guerin PJ; Sharma A
Am J Trop Med Hyg; 2024 May; 110(5):910-920. PubMed ID: 38574550
[TBL] [Abstract][Full Text] [Related]
28. Molecular Determinants of Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum Isolates from Central Africa between 2016 and 2021: Wide Geographic Spread of Highly Mutated
Wang X; Zhang X; Chen H; Lu Q; Ruan W; Chen Z
Microbiol Spectr; 2022 Oct; 10(5):e0200522. PubMed ID: 36121226
[TBL] [Abstract][Full Text] [Related]
29. Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.
Mensah BA; Aydemir O; Myers-Hansen JL; Opoku M; Hathaway NJ; Marsh PW; Anto F; Bailey J; Abuaku B; Ghansah A
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932374
[TBL] [Abstract][Full Text] [Related]
30. Geographical emergence of sulfadoxine-pyrimethamine drug resistance-associated
Nkemngo FN; Raissa LW; Nguete DN; Ndo C; Fru-Cho J; Njiokou F; Wanji S; Wondji CS
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0058823. PubMed ID: 37947766
[TBL] [Abstract][Full Text] [Related]
31. Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso.
Somé FA; Bazié T; Ehrlich HY; Goodwin J; Lehane A; Neya C; Zachari K; Wade M; Ouattara JM; Foy BD; Dabiré RK; Parikh S; Ouédraogo JB
Malar J; 2020 Jul; 19(1):238. PubMed ID: 32631416
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of molecular markers of resistance to sulfadoxine-pyrimethamine before and after community delivery of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa: a multi-country evaluation.
Figueroa-Romero A; Bissombolo D; Meremikwu M; Ratsimbasoa A; Sacoor C; Arikpo I; Lemba E; Nhama A; Rakotosaona R; Llach M; Pons-Duran C; Sanz S; Ma L; Doderer-Lang C; Maly C; Roman E; Pagnoni F; Mayor A; Menard D; González R; Menéndez C
Lancet Glob Health; 2023 Nov; 11(11):e1765-e1774. PubMed ID: 37858587
[TBL] [Abstract][Full Text] [Related]
33. Seasonal Malaria Chemoprevention Drug Levels and Drug Resistance Markers in Children With or Without Malaria in Burkina Faso: A Case-Control Study.
Roh ME; Zongo I; Haro A; Huang L; Somé AF; Yerbanga RS; Conrad MD; Wallender E; Legac J; Aweeka F; Ouédraogo JB; Rosenthal PJ
J Infect Dis; 2023 Oct; 228(7):926-935. PubMed ID: 37221018
[TBL] [Abstract][Full Text] [Related]
34. Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.
Yaro JB; Tiono AB; Ouedraogo A; Lambert B; Ouedraogo ZA; Diarra A; Traore A; Lankouande M; Soulama I; Sanou A; Worrall E; Agboraw E; Sagnon N; Ranson H; Churcher TS; Lindsay SW; Wilson AL
Sci Rep; 2022 Jan; 12(1):1402. PubMed ID: 35082312
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis on Plasmodium falciparum sulfadoxine-pyrimethamine resistance-conferring mutations in India identifies hot spots for genetic surveillance.
Sinha A; Kar S; Chauhan C; Yadav CP; Kori L
Int J Antimicrob Agents; 2024 Mar; 63(3):107071. PubMed ID: 38154659
[TBL] [Abstract][Full Text] [Related]
36. Sub-microscopic Plasmodium falciparum infections and multiple drug resistant single nucleotide polymorphic alleles in pregnant women from southwestern Nigeria.
Ibekpobaoku AN; Oboh MA; Faal F; Adeniji E; Ajibaye O; Idowu ET; Amambua-Ngwa A
BMC Res Notes; 2024 May; 17(1):129. PubMed ID: 38725016
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India.
Singh A; Singh MP; Ali NA; Poriya R; Rajvanshi H; Nisar S; Bhandari S; Sahu RS; Jayswar H; Mishra AK; Das A; Kaur H; Anvikar AR; Escalante AA; Lal AA; Bharti PK
Malar J; 2023 Dec; 22(1):375. PubMed ID: 38072967
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
Conteh L; Patouillard E; Kweku M; Legood R; Greenwood B; Chandramohan D
PLoS One; 2010 Aug; 5(8):e12223. PubMed ID: 20808923
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali.
Diakité SAS; Traoré K; Sanogo I; Clark TG; Campino S; Sangaré M; Dabitao D; Dara A; Konaté DS; Doucouré F; Cissé A; Keita B; Doumbouya M; Guindo MA; Toure MB; Sogoba N; Doumbia S; Awandare GA; Diakité M
Malar J; 2019 Nov; 18(1):361. PubMed ID: 31718631
[TBL] [Abstract][Full Text] [Related]
40. Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention.
Thwing J; Williamson J; Cavros I; Gutman JR
Am J Trop Med Hyg; 2024 Jan; 110(1):20-31. PubMed ID: 38081050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
